Summary
Fredericamycin is an antibiotic product of Streptomyces griseus that exhibits modest antitumor activity in vivo and in vitro. Because of its unique structure and the absence of a clearly defined mechanism of action, we examined the effects of this compound on L1210 cells in culture as well as on several enzymes that bind to DNA. Fredericamycin exhibits an IC50 of 4.4 μM toward L1210 cells, and its cytotoxicity is a function of the time of exposure as well as drug dose. No DNA breakage was observed in L1210 cells or isolated nuclei following exposure to highly lethal concentrations of fredericamycin. As a first step toward understanding its mechanism of action, we examined the effect of fredericamycin on several enzymes involved in DNA metabolism. The catalytic activity of both DNA topoisomerases I and II were totally inhibited by fredericamycin concentrations of 4.4 and 7.4 μM, respectively. Fredericamycin blocked etoposide-stimulated DNA cleavage by topoisomerase II both in vitro and in isolated nuclei. In addition, the drug inhibits DNA polymerase a in vitro, exhibiting an IC50 of 93 μM. These diverse actions of fredericamycin do not enable us to draw conclusions regarding its mechanism of antitumor effect but clearly identify it as a compound of pharmacologic interest.
Similar content being viewed by others
References
Boritzki TJ, Hann FS, Roberts BJ, Cheng YC, Jackson RC (1986) Inhibitory effects of fostriecin (CI-920) related analogs on eukaryotic type II topoisomerase. Proc Am Assoc Cancer Res 27: 276
Drake FH, Zimmerman JP, Bartus HF, Hofmann GA, Per SR, Mattern MR, Mirabelli CK, Johnson RK, Ross WE, Sullivan D, Crooke ST (1987) Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. J Biol Chem 262: 16739
Fesen MR, Pommier Y (1988) Topoisomerase inhibition by anticancer drugs is antagonized by distamycin. Proc Am Assoc Cancer Res 29: 276
Filipski J, Yin J, Kohn KW (1983) Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts. Biochim Biophys Acta 741: 116
Hilton BD, Misra R (1986) Magnetic resonance studies of fredericamycin A: evidence for O2-dependent free-radical formation. Biochemistry 25: 5533
Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260: 14873
Johnson RK, Hofmann GS, Bartus HF, Mong SM, Mirabelli CK (1988) Inhibition of topoisomerase II by merbarone. Proc Am Assoc Cancer Res 29: 328
Kelly TR, Ohashi N, Armstrong-Chong RJ, Bell SH (1986) Synthesis of (+)-fredericamycin A. J Am Chem Soc 108: 7100
Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and cross-links by alkaline elution. In: Friedberg EC, Hanawalt PC (eds) DNA repair: a laboratory manual of research techniques. Marcel Dekker, New York, p 379
Liu LF, Davis JL, Calendar R (1981) Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases. Nucleic Acids Res 9: 3979
Liu LF, Rowe TC Yang L, Tewey KW, Chen GL (1983) Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem 258: 15365
McHugh MM, Sigmund R, Beerman RA (1988) Effect of minor groove binders on DNA reactivity of the topoisomerase I inhibitor camptothecin in L1210 nuclei. Proc Am Assoc Cancer Res 29: 274
Misra R, Pandey RC, Hilton BD (1987) Structure of fredericamycin A, an antitumor antibiotic of a novel skeletal type: spectroscopic and mass spectral characterization. J Antibiot 40: 787
Ross WE (1985) DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 34: 4191
Warnick-Pickle DJ, Byrne KM, Pandey RC, White RJ (1981) Fredericamycin A, a new antitumor antibiotic: II. Biological properties. J Antibiot 34: 1402
Wozniak AJ, Ross WE (1983) DNA damage as a basis for 4′-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-d-glucopyr-anoside) (etoposide) cytotoxicity. Cancer Res 43: 120
Author information
Authors and Affiliations
Additional information
Supported by USPHS grant CA-40884
Rights and permissions
About this article
Cite this article
Latham, M.D., King, C.K., Gorycki, P. et al. Inhibition of topoisomerases by fredericamycin A. Cancer Chemother. Pharmacol. 24, 167–171 (1989). https://doi.org/10.1007/BF00300237
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00300237